Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
enrolled participants were treated orally with SOF plus a fixed dose combination of OBV/PTV/r plus RBV.
Epistemonikos ID: f201586dedbb79d9f4a6849eb9d8ae536e94de5e
First added on: May 07, 2024